345 related articles for article (PubMed ID: 8019748)
1. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
Clarke PB; Reuben M; el-Bizri H
Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748
[TBL] [Abstract][Full Text] [Related]
2. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
3. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.
el-Bizri H; Clarke PB
Br J Pharmacol; 1994 Feb; 111(2):406-13. PubMed ID: 8004384
[TBL] [Abstract][Full Text] [Related]
4. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats.
Xiao WB; Nordberg A; Zhang X
J Pharmacol Exp Ther; 1993 May; 265(2):759-64. PubMed ID: 8496822
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
Sidhpura N; Redfern P; Wonnacott S
Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
[TBL] [Abstract][Full Text] [Related]
6. Tacrine and physostigmine block nicotinic receptors in Xenopus oocytes injected with Torpedo electroplaque membranes.
Cantà C; Bodas E; Marsal J; Solsona C
Eur J Pharmacol; 1998 Dec; 363(2-3):197-202. PubMed ID: 9881590
[TBL] [Abstract][Full Text] [Related]
7. Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells.
Sugawara T; Ohta T; Asano T; Ito S; Nakazato Y
Eur J Pharmacol; 1997 Jan; 319(1):123-30. PubMed ID: 9030907
[TBL] [Abstract][Full Text] [Related]
8. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Galli A; Mori F; Gori I; Lucherini M
Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
[TBL] [Abstract][Full Text] [Related]
9. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
Dwoskin LP; Teng L; Buxton ST; Crooks PA
J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
Sacaan AI; Dunlop JL; Lloyd GK
J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats.
Giarola A; Auber A; Chiamulera C
Behav Pharmacol; 2011 Feb; 22(1):1-6. PubMed ID: 21116174
[TBL] [Abstract][Full Text] [Related]
12. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
[TBL] [Abstract][Full Text] [Related]
13. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices.
Wilkins LH; Haubner A; Ayers JT; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2002 Jun; 301(3):1088-96. PubMed ID: 12023541
[TBL] [Abstract][Full Text] [Related]
14. Blockade of cardiac nicotinic responses by anticholinesterases.
Paddle BM; Dowling MH
Gen Pharmacol; 1996 Jul; 27(5):861-72. PubMed ID: 8842691
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms.
Robinson TN; De Souza RJ; Cross AJ; Green AR
Br J Pharmacol; 1989 Dec; 98(4):1127-36. PubMed ID: 2611486
[TBL] [Abstract][Full Text] [Related]
16. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs.
Zwart R; van Kleef RG; Gotti C; Smulders CJ; Vijverberg HP
J Neurochem; 2000 Dec; 75(6):2492-500. PubMed ID: 11080202
[TBL] [Abstract][Full Text] [Related]
17. Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes.
Reuben M; Clarke PB
Neuropharmacology; 2000 Jan; 39(2):290-9. PubMed ID: 10670424
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.
Teng L; Crooks PA; Buxton ST; Dwoskin LP
J Pharmacol Exp Ther; 1997 Nov; 283(2):778-87. PubMed ID: 9353398
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Caricati-Neto A; D'angelo LC; Reuter H; Hyppolito Jurkiewicz N; Garcia AG; Jurkiewicz A
Eur J Pharmacol; 2004 Oct; 503(1-3):191-201. PubMed ID: 15496314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
